Kefeng Wang
Shenzhen, 518055, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Discovery of a potent and selective PROTAC degrader for STAT3.
Journal: RSC medicinal chemistry
Published: March 26, 2025
Right versus left thoracic approach esophagectomy for patients with neoadjuvant immunochemotherapy.
Journal: Annals of medicine
Published: January 25, 2025
Abnormal expression of CDC25C in NSCLC is influenced by transcriptional and RNA N6‑methyladenosine‑mediated post‑transcriptional regulation.
Journal: International journal of oncology
Published: September 18, 2024
RNA methylation of CD47 mediates tumor immunosuppression in EGFR-TKI resistant NSCLC.
Journal: British journal of cancer
Published: August 12, 2024
Single-cell analysis reveals transcriptomic features and therapeutic targets in primary pulmonary lymphoepithelioma-like carcinoma.
Journal: Communications biology
Published: May 06, 2024
Global miRNA profiling reveals key molecules that contribute to different chronic lymphocytic leukemia incidences in Asian and Western populations.
Journal: Haematologica
Published: March 21, 2023
A propensity score-matched analysis of neoadjuvant chemoimmunotherapy versus surgery alone for locally advanced esophageal squamous cell carcinoma.
Journal: Journal of surgical oncology
Published: December 08, 2022
The comparison of manual and mechanical anastomosis after total pharyngolaryngoesophagectomy.
Journal: Frontiers in oncology
Published: September 10, 2022
Development and clinical validation of a necroptosis-related gene signature for prediction of prognosis and tumor immunity in lung adenocarcinoma.
Journal: American journal of cancer research
Published: August 20, 2022
Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma.
Journal: Oxidative medicine and cellular longevity
Published: July 29, 2022
A novel protein encoded by circUBE4B promotes progression of esophageal squamous cell carcinoma by augmenting MAPK/ERK signaling.
Journal: Cell death & disease
Published: June 16, 2022
Last Updated: 09/26/2026